Administration period: 25–365 days (mean: 195 days)
Participants: 48 (16 male, 32 female)
Age: 58–98 years (mean: 79 years)
Dosage: 1–4 capsules/day (mean: 2.8 capsules)
Outcomes after approximately 6 months:
Triglyceride levels decreased from approximately 140 mg/dL to 100 mg/dL (mean values)
Systolic blood pressure decreased from approximately 150 mmHg to 138 mmHg (mean values)
Diastolic blood pressure decreased from approximately 83 mmHg to 78 mmHg (mean values)
